Skip to main content

APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.

Publication ,  Journal Article
Tachibana, M; Holm, M-L; Liu, C-C; Shinohara, M; Aikawa, T; Oue, H; Yamazaki, Y; Martens, YA; Murray, ME; Sullivan, PM; Weyer, K; Glerup, S ...
Published in: J Clin Invest
March 1, 2019

Carrying the ε4 allele of the APOE gene encoding apolipoprotein E (APOE4) markedly increases the risk for late-onset Alzheimer's disease (AD), in which APOE4 exacerbates the brain accumulation and subsequent deposition of amyloid-β (Aβ) peptides. While the LDL receptor-related protein 1 (LRP1) is a major apoE receptor in the brain, we found that its levels are associated with those of insoluble Aβ depending on APOE genotype status in postmortem AD brains. Thus, to determine the functional interaction of apoE4 and LRP1 in brain Aβ metabolism, we crossed neuronal LRP1-knockout mice with amyloid model APP/PS1 mice and APOE3-targeted replacement (APO3-TR) or APOE4-TR mice. Consistent with previous findings, mice expressing apoE4 had increased Aβ deposition and insoluble amounts of Aβ40 and Aβ42 in the hippocampus of APP/PS1 mice compared with those expressing apoE3. Intriguingly, such effects were reversed in the absence of neuronal LRP1. Neuronal LRP1 deficiency also increased detergent-soluble apoE4 levels, which may contribute to the inhibition of Aβ deposition. Together, our results suggest that apoE4 exacerbates Aβ pathology through a mechanism that depends on neuronal LRP1. A better understanding of apoE isoform-specific interaction with their metabolic receptor LRP1 on Aβ metabolism is crucial for defining APOE4-related risk for AD.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Invest

DOI

EISSN

1558-8238

Publication Date

March 1, 2019

Volume

129

Issue

3

Start / End Page

1272 / 1277

Location

United States

Related Subject Headings

  • Peptide Fragments
  • Mice, Knockout, ApoE
  • Mice
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Immunology
  • Humans
  • Hippocampus
  • Disease Models, Animal
  • Apolipoprotein E4
  • Animals
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tachibana, M., Holm, M.-L., Liu, C.-C., Shinohara, M., Aikawa, T., Oue, H., … Kanekiyo, T. (2019). APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1. J Clin Invest, 129(3), 1272–1277. https://doi.org/10.1172/JCI124853
Tachibana, Masaya, Marie-Louise Holm, Chia-Chen Liu, Mitsuru Shinohara, Tomonori Aikawa, Hiroshi Oue, Yu Yamazaki, et al. “APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.J Clin Invest 129, no. 3 (March 1, 2019): 1272–77. https://doi.org/10.1172/JCI124853.
Tachibana M, Holm M-L, Liu C-C, Shinohara M, Aikawa T, Oue H, et al. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1. J Clin Invest. 2019 Mar 1;129(3):1272–7.
Tachibana, Masaya, et al. “APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.J Clin Invest, vol. 129, no. 3, Mar. 2019, pp. 1272–77. Pubmed, doi:10.1172/JCI124853.
Tachibana M, Holm M-L, Liu C-C, Shinohara M, Aikawa T, Oue H, Yamazaki Y, Martens YA, Murray ME, Sullivan PM, Weyer K, Glerup S, Dickson DW, Bu G, Kanekiyo T. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1. J Clin Invest. 2019 Mar 1;129(3):1272–1277.

Published In

J Clin Invest

DOI

EISSN

1558-8238

Publication Date

March 1, 2019

Volume

129

Issue

3

Start / End Page

1272 / 1277

Location

United States

Related Subject Headings

  • Peptide Fragments
  • Mice, Knockout, ApoE
  • Mice
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Immunology
  • Humans
  • Hippocampus
  • Disease Models, Animal
  • Apolipoprotein E4
  • Animals